Red Cell Distribution Width and Mortality in Hemodialysis Patients: A Single Center Experience in COVID-19 Era

Authors

  • Mustafa Topal Clinic of Nephrology, Konya City Hospital, University of Health Sciences, Turkey.
  • Ibrahim Guney Clinic of Nephrology, Konya City Hospital, University of Health Sciences, Turkey.

Keywords:

Red cell distribution width, Hemodialysis, Mortality, COVID-19, Chronic kidney disease, Rheumatoid arthtritis

Abstract

Abstract: Introduction: Red Cell Distribution width (RDW) is found to be related with mortality in hemodialysis patients. In December 2019, a new corona virus spread was detected in China, which turned into a pandemia with significant mortality. Both RDW and chronic kidney disease were found to be related with mortality in COVID-19 patients. This study investigated if the association of RDW and mortality in hemodialysis patients still existed in the COVID-19 era.

Materials & Methods: This single center study included 117 hemodialysis patients. They were followed for 20 months (between December 2019 and July 2021) or until death. The relation of RDW with all-cause mortality and COVID-19 related deaths were studied.

Results: 21 (17.9%) out of 117 patients died during the follow-up. RDW was found to be an independent risk factor for all-cause mortality (HR:1.35, p=0.009). In post-hoc analyzes, RDW was significantly higher in non-COVID-19 related and cardiovascular deaths.

Conclusion: RDW was found to be an independent and powerful risk factor of all-cause and cardiovascular mortality even in the mortal
COVID-19 era.

Downloads

Published

2022-03-07

How to Cite

1.
Topal M, Guney I. Red Cell Distribution Width and Mortality in Hemodialysis Patients: A Single Center Experience in COVID-19 Era. Nat J Health Sci [Internet]. 2022Mar.7 [cited 2024Apr.20];6(2):61-6. Available from: https://ojs.njhsciences.com/index.php/njhs/article/view/210

Issue

Section

Research Article